Rodríguez-Jorge, Fernando; Fernández-Velasco, José-Ignacio; Villarrubia, Noelia; Gracia-Gil, Julia; Fernández, Eva; Meca-Lallana, Virginia; Diaz-Pérez, Carolina; Sainz-de-la-Maza, Susana; Pacheco, Eva-María; Quiroga, Ana; Ramio-Torrenta, Lluis; Martínez-Yelamos, Sergio; Bau, Laura; Monreal, Enric; López-Real, Ana; Rodero-Romero, Alexander; Borrega, Laura; Diaz, Santiago; Eguia, Pablo; Espino, Mercedes; Chico-García, Juan-Luis; Barrero, Francisco-Javier; Martínez-Gines, María-Luisa; García-Domínguez, José-Manuel; De-la-Fuente, Soraya; Moreno, Irene; Sainz-Amo, Raquel; Mane-Martínez, MAlba; Caminero, Ana; Castellanos, Fernando; Gómez-López, Ana; Labiano-Fontcuberta, Andres; Ayuso, Lucia; Abreu, Rossana; Hernández, Miguel-Angel; Meca-Lallana, José; Martín-Aguilar, Lorena; Muriel-García, Alfonso; Masjuan, Jaime; Costa-Frossard, Lucienne; Villar, Luisa-María
(FRONTIERS MEDIA SA, 2024-11)
OBJECTIVE: To ascertain the changes of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) values in relapsing-remitting multiple sclerosis (RRMS) patients treated with ocrelizumab and their ...